Diurnal Group (LON:DNL) Stock Price Up 1.6%

Shares of Diurnal Group PLC (LON:DNL) rose 1.6% during mid-day trading on Wednesday . The company traded as high as GBX 33.50 ($0.44) and last traded at GBX 32.50 ($0.42), approximately 49,314 shares were traded during mid-day trading. An increase of 564% from the average daily volume of 7,428 shares. The stock had previously closed at GBX 32 ($0.42).

The business has a 50 day moving average of GBX 36.61 and a 200-day moving average of GBX 31.09. The stock has a market cap of $27.51 million and a PE ratio of -1.19.

In other Diurnal Group news, insider Richard Bungay purchased 8,000 shares of Diurnal Group stock in a transaction on Monday, June 24th. The shares were bought at an average price of GBX 30 ($0.39) per share, with a total value of £2,400 ($3,136.03). Also, insider Martin Whitaker sold 44,810 shares of the stock in a transaction on Tuesday, August 6th. The stock was sold at an average price of GBX 37 ($0.48), for a total value of £16,579.70 ($21,664.31).

Diurnal Group Company Profile (LON:DNL)

Diurnal Group plc operates as a specialty pharma company. The company develops hormone therapeutics for the treatment of chronic endocrine conditions, including congenital adrenal hyperplasia, adrenal insufficiency, hypogonadism, and hypothyroidism. Its product pipeline includes Infacort for use in children suffering from adrenal insufficiency; and Chronocort, which completed Phase III clinical trials targeting congenital adrenal hyperplasia in adult patients, as well as adrenal insufficiency.

Featured Story: What are catch-up contributions?

Receive News & Ratings for Diurnal Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diurnal Group and related companies with MarketBeat.com's FREE daily email newsletter.